RecruitingPhase 3NCT07596199
Rare condition
Whooping cough
15
studies recruiting now
as of 7 Sept 2026
417
studies registered in total
as of 7 Sept 2026
5
countries with a recruiting site
as of 7 Sept 2026
19 May 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 4NCT07097012
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
RecruitingNot applicableNCT05847322
Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
RecruitingNot applicableNCT06815250
Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial
RecruitingNCT07358910
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 15 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Whooping cough study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Whooping cough
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
8 approved treatments and 3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Bordetella Pertussis Filamentous Hemagglutinin (Bordetella pertussis filamentous hemagglutinin component of hexacima)Approved: Bordetella Pertussis Toxin (Bordetella pertussis toxin component of triacelluvax)Approved: Bordetella Pertussis Pertactin Autotransporter (Bordetella pertussis pertactin autotransporter component of infanrix hepb)Approved: Diphtheria Toxoid (Diphtheria toxoid component of hexacima)Approved: Tetanus Toxoid (Equilis te)Approved: Hepatitis B Virus Hbsag Surface Protein Antigen (Ambirix)Approved: Erythromycin Ethylsuccinate (Anamycin)Approved: Erythromycin (A/t/s)
Phase 3Pertussis Vaccine
Phase 3Human Immunoglobulin G (Flebogamma dif (previously flebogammadif))
Phase 2Azithromycin (Azasite)
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).